de Graaf Hans, Pelosi Emanuela, Cooper Andrea, Pappachan John, Sykes Kim, MacIntosh Iain, Gbesemete Diane, Clark Tristan W, Patel Sanjay V, Faust Saul N, Tebruegge Marc
From the *Academic Unit of Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom; †Southampton NIHR Wellcome Trust Clinical Research Facility, ‡Department of Infection, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; §Public Health England Microbiology Services, Southampton, United Kingdom; ¶Department of Paediatric Intensive Care, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; ‖Institute for Life Sciences, University of Southampton, Southampton, United Kingdom; **Department of Paediatric Immunology & Infectious Diseases, ††NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; ‡‡Global Health Research Institute, University of Southampton, Southampton, United Kingdom; and §§Department of Paediatrics, The University of Melbourne, Parkville, Australia.
Pediatr Infect Dis J. 2016 Jul;35(7):723-7. doi: 10.1097/INF.0000000000001093.
Most enterovirus surveillance studies lack detailed clinical data, which limits their clinical usefulness. This study aimed to describe the clinical spectrum and outcome of severe enterovirus infections in children, and to determine whether there are associations between causative enterovirus genotypes and clinical phenotypes.
Retrospective analysis of microbiological and clinical data from a tertiary children's hospital in the South of England over a 17-month period (2012-2013).
In total, 30 patients were identified, comprising sepsis (n = 9), myocarditis (n = 8), meningitis (n = 8) and encephalitis (n = 5). Cases with sepsis or myocarditis were significantly younger than those with central nervous system disease (median age 21 and 15 days vs. 79 days; P = 0.0244 and P = 0.0310, respectively). There was considerable diversity in the causative genotypes in each of the clinical phenotypes, with some predominance of echoviruses in the meningitis group, and coxsackie B viruses in the myocarditis group. Thirteen cases required mechanical ventilation, 11 cases inotropic support, 3 cases dialysis and 3 cases extracorporal membrane oxygenation. The overall mortality was 10% (sepsis group, n = 1; myocarditis group, n = 2). Of the survivors, 5 (19%) had long-term sequelae (myocardial dysfunction, n = 2; neurological sequelae, n = 3). Patients with encephalitis had the longest hospital stay (median: 16 days), compared with 9, 6 and 3 days in patients with myocarditis, sepsis and meningitis, respectively (P = 0.005).
Enterovirus infections, particularly enteroviral myocarditis and encephalitis, can cause significant morbidity and mortality. The results show that there are currently no strong associations between clinical phenotypes and particular causative enterovirus genotypes in the South of England.
大多数肠道病毒监测研究缺乏详细的临床数据,这限制了它们在临床上的实用性。本研究旨在描述儿童严重肠道病毒感染的临床谱和结局,并确定致病肠道病毒基因型与临床表型之间是否存在关联。
对英国南部一家三级儿童医院17个月期间(2012 - 2013年)的微生物学和临床数据进行回顾性分析。
共确定30例患者,包括败血症(n = 9)、心肌炎(n = 8)、脑膜炎(n = 8)和脑炎(n = 5)。败血症或心肌炎患者明显比中枢神经系统疾病患者年龄小(中位年龄分别为21天和15天,而中枢神经系统疾病患者为79天;P = 0.0244和P = 0.0310)。每种临床表型的致病基因型存在相当大的差异,脑膜炎组中埃可病毒占一定优势,心肌炎组中柯萨奇B病毒占一定优势。13例患者需要机械通气,11例需要血管活性药物支持,3例需要透析,3例需要体外膜肺氧合。总体死亡率为10%(败血症组,n = 1;心肌炎组,n = 2)。在幸存者中,5例(19%)有长期后遗症(心肌功能障碍,n = 2;神经后遗症,n = 3)。脑炎患者住院时间最长(中位:16天),心肌炎、败血症和脑膜炎患者的住院时间分别为9天、6天和3天(P = 0.005)。
肠道病毒感染,特别是肠道病毒性心肌炎和脑炎,可导致严重的发病和死亡。结果表明,目前在英国南部临床表型与特定致病肠道病毒基因型之间没有很强的关联。